Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Med (New York, N.Y.)|February 12, 2026
Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cellsKhanh Ha Nguyen, Soumyajit Das, Sandro MatosevicMolecular Pharmaceutics|January 17, 2024
Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector ResponsesSoumyajit Das, Emmett Niemeyer, Zach A Leung, et al.Current Protocols|November 25, 2025
Isolation and Flow Cytometric Analysis of Natural Killer Cells from Human Glioblastoma Multiforme (GBM) TissuesSoumyajit Das, Kyle B Lupo, Veronika Slivova, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2026
SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloadsSoumyajit Das, Khanh Ha Nguyen, Tyler Fritsch, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 29, 2012
Synthesizing artificial cells from giant unilamellar vesicles: state-of-the art in the development of microfluidic technologySandro MatosevicJournal of Immunology Research|October 12, 2018
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesSandro MatosevicDrug Delivery|May 6, 2016
Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscapeClaudia Zylberberg, Sandro MatosevicTherapeutic Delivery|May 23, 2017
Bioengineered liposome-scaffold composites as therapeutic delivery systemsClaudia Zylberberg, Sandro MatosevicCellular Oncology (Dordrecht, Netherlands)|June 4, 2020
Functional and metabolic targeting of natural killer cells to solid tumorsJiao Wang, Sandro MatosevicBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 24, 2021
Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based ImmunotherapyXue Yao, Sandro MatosevicPageof 11